Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy

Epilepsia

Volumn 50, Issue 3, 2009, Pages 434-442

  Labiner, David M ^a   Ettinger, Alan B ^b   Fakhoury, Toufic A ^c   Chung, Steve S ^d   Shneker, Bassel ^e   Tatum Iv, William O ^f   Mitchell Miller, J ^g   Vuong, Alain ^g   Hammer, Anne E ^g   Messenheimer, John A ^g  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b North Shore LIJ Comprehensive Epilepsy Centers   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^d BARROW NEUROLOGICAL INSTITUTE   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g GLAXOSMITHKLINE   (United States)

Author keywords

Antiepileptic drugs; Clinical trials; Epilepsy seizures; Partial seizures

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; LAMOTRIGINE;

ADJUVANT THERAPY; ADULT; ANGER; ANTICONVULSANT THERAPY; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG WITHDRAWAL; EPILEPSY; EVENING DOSAGE; FATIGUE; FEMALE; FOCAL EPILEPSY; HEADACHE; HOSTILITY; HUMAN; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MOOD; MORNING DOSAGE; NAUSEA; NERVOUSNESS; PRIORITY JOURNAL; PROFILE OF MOOD STATES; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; RASH; RHINOPHARYNGITIS; SCORING SYSTEM; SEIZURE; SIDE EFFECT; SINUSITIS; SOMNOLENCE; SORE THROAT; STATE-TRAIT ANGER EXPRESSION INVENTORY; SUICIDAL IDEATION; TOOTH PAIN; TREATMENT OUTCOME; VOMITING;

ADULT; AFFECT; ANGER; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; HOSTILITY; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PIRACETAM; PSYCHOMETRICS; TRIAZINES;

EID: 61849184228     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01792.x     Document Type: Article

References (31)

1. Abou-Khalil B 2005) Benefit:risk assessment of levetiracetam in the treatment of partial seizures. Drug Saf 28 : 871 890.
2. Beck AT, Brown G, Steer RA. (1996) Beck Depression Inventory II manual. The Psychological Corporation, San Antonio, TX.
3. Besag FMC 2001) Behavioural effects of the new anticonvulsants. Drug Saf 24 : 513 536.
4. Bhagwagar Z, Goodwin GM 2005) Lamotrigine in the treatment of bipolar disorder. Expert Opin Pharmacother 6 : 1401 1408.
5. Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP 2007) Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav 10 : 296 303.
6. Boylan LS, Flint LA, Labovitz DL, Jackson SC, Stamer K, Devinsky O 2004) Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 62 : 258 261.
7. Centers for Disease Control and Prevention (CDC) 2001) Health-related quality of life among persons with epilepsy - Texas, 1998. MMWR Morb Mortal Wkly Rep 50 : 24 26, 35.
8. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I 2000) Levetiracetam for partial seizures. Results of a double-blind, randomized clinical trial. Neurology 55 : 236 242.
9. Chadwick D, Privitera M 2006) How skeptical should we be about industry-sponsored studies? Neurology 67 : 378 379.
10. Chung SS, Wang N, Hank N 2007) Comparative retention rates and long-term tolerability of new antiepileptic drugs. Seizures 16 : 296 304.
11. Cramer JA, De Rue K, Devinsky O, Edrich P, Trimble MR 2003) A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy Behav 4 : 124 132.
12. Edwards KR, Sackellares JC, Vuong A, Hammer AE, Barrett PS 2001) Lamotrigine monotherapy improves depressive symptoms in epilepsy: a double-blind comparison with valproate. Epilepsy Behav 2 : 28 36.
13. Ettinger AB, Kustra RP, Hammer AE 2007) Effect of lamotrigine on depressive symptoms in adult patients with epilepsy. Epilepsy Behav 10 : 148 154.
14. Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R 1997) Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 38 : 233 236.
15. Gilliam F 2002) Optimizing health outcomes in active epilepsy. Neurology 58 : 9 20.
16. Gilliam FG 2005) Epilepsy - success in clinical practice: translating trials to practice. Eur J Neurol 12 (Suppl. 4 22 29.
17. Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM 2006) Rapid detection of major depression in epilepsy: a multicenter study. Lancet Neurol 5 : 399 405.
18. Guy W 1976) ECDEU assessment manual for psychopharmacology, revised (DHEW Pub No ADM 76-338). US Department of Health, Education, and Welfare, Public Health Service; Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville, MD, pp. 218 222.
19. Johns MW 1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14 : 540 545.
20. Johnson EK, Jones JE, Seidenberg M, Hermann BP 2004) The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 45 : 544 550.
21. Kalogjera-Sackellares D, Sackellares JC 2002) Improvement in depression associated with partial epilepsy in patients treated with lamotrigine. Epilepsy Behav 3 : 510 516.
22. Martinović Z, Buder N, Milovanović M, Velić ković R 2004) Antiepileptic, behavioral, and antidepressant effects of adjuvant lamotrigine therapy in drug-resistant epilepsy. Vojnosanit Pregl 61 : 485 490.
23. Matsuo F, Bergen D, Faught E, Messenheimer JA, Dren AT, Rudd GD, Lineberry CG 1993) Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 05 Clinical Trial Group. Neurology 43 : 2284 2291.
24. McNair DM, Lorr M, Droppleman LF. (1971) EITS manual for the profile of mood states. Educational and Industrial Testing Service, San Diego, CA.
25. Messenheimer J, Mullens EL, Giorgi L, Young F 1998) Safety review of adult clinical trial experience with lamotrigine. Drug Saf 18 : 281 296.
26. Mula M, Trimble MR, Yuen R, Riu RS, Sander JW 2003) Psychiatric adverse events during levetiracetam therapy. Neurology 61 : 704 706.
27. Perrine K, Hermann BP, Meador KJ, Vickrey BG, Cramer JA, Hays RD, Devinsky O 1995) The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 52 : 997 1003.
28. Snaith RP, Constantopolous AA, Jardine MY, McGuffin P 1978) A clinical scale for the self-assessment of irritability. Br J Psychiatry 132 : 164 171.
29. Spielberger CD, Johnson EH, Russell SF, Crane RJ, Jacobs GA, Worden TJ 1985) The experience and expression of anger: construction and validation of an anger expression scale. In Chesney MA, Rosenman RH (Eds) Anger and hostility in cardiovascular and behavioral disorders. Hemisphere/McGraw-Hill, New York, pp. 5 30.
30. Weintraub D, Buchsbaum R, Resor SR Jr., Hirsch LJ 2007) Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Epilepsy Behav 10 : 105 110.
31. White JR, Walczak TS, Leppik J, Rarick J, Tran T, Beniak TE, Matchinsky DJ, Gumnit RJ 2003) Discontinuation of levetiracetam because of behavioral side effects: a case control study. Neurology 61 : 1218 1221.